Clinical Comparison of Two Daily Disposable Contact Lenses - Pilot Study 3
Launched by ALCON RESEARCH · Jun 21, 2021
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The expected duration of subject participation in the study is up to 24 days with 3 scheduled visits.
Gender
ALL
Eligibility criteria
- Key Inclusion Criteria:
- • Able to understand and sign an Informed Consent Form that been approved by an Institutional Review Board.
- • Successful wear of spherical soft contact lenses in both eyes for a minimum of 5 days per week and 10 hours per day during the past 3 months.
- • Other protocol-defined inclusion criteria may apply.
- Key Exclusion Criteria:
- • Current/previous PRECISION1 or INFUSE contact lens wearer.
- • Any eye condition or use of medication that contraindicates contact lens wear, as determined by the investigator.
- • Routinely sleeps in contact lenses.
- • Other protocol-defined exclusion criteria may apply.
About Alcon Research
Alcon Research is a leading global company dedicated to advancing eye care through innovative research and development. As a subsidiary of Novartis, Alcon focuses on the development of cutting-edge products and therapies for vision correction and eye health, including surgical, pharmaceutical, and consumer eye care solutions. With a commitment to enhancing the quality of life for patients worldwide, Alcon Research conducts rigorous clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of care. Through collaboration with healthcare professionals and institutions, Alcon remains at the forefront of ophthalmic advancements, driving progress in the field of vision science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maitland, Florida, United States
Orlando, Florida, United States
Powell, Ohio, United States
Eden Prairie, Minnesota, United States
Patients applied
Trial Officials
Clinical Trial Lead, Vision Care
Study Director
Alcon Research, LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials